Management of a Sabiá virus-infected patients in a US hospital.
OBJECTIVE
To describe the hospital precautions used to isolate a Sabiá virus (arenavirus: Arenaviridae)-infected patient in a US hospital and to protect hospital staff and visitors.


METHODS
Investigation of a single case of arenavirus laboratory-acquired infection and associated case-contacts.


METHODS
A 900-bed, tertiary-care, university-affiliated medical center.


METHODS
The case-patient became ill with Sabiá virus infection. The case-contacts consisted of healthcare workers, coworkers, friends, and relatives of the case-patient.


METHODS
Enhanced isolation precautions for treatment of a viral hemorrhagic fever (VHF) patient were implemented in the clinical laboratory and patient-care setting to prevent nosocomial transmission. The enhanced precautions included preventing aerosol spread of the virus from the patient or his clinical specimens. All case-contacts were tested for Sabiá virus antibodies and monitored for signs and symptoms of early disease.


RESULTS
No cases of secondary infection occurred among 142 case-contacts.


CONCLUSIONS
With the frequency of worldwide travel, patients with VHF can be admitted to a local hospital at any time in the United States. The use of enhanced isolation precautions for VHF appeared to be effective in preventing secondary cases by limiting the number of contacts and promoting proper handling of laboratory specimens. Patients with VHF can be managed safely in a local hospital setting, provided that appropriate precautions are planned and implemented.
Armstrong
L R
LR
Viral Exanthems and Herpesvirus Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Dembry
L M
LM
Rainey
P M
PM
Russi
M B
MB
Khan
A S
AS
Fischer
S H
SH
Edberg
S C
SC
Ksiazek
T G
TG
Rollin
P E
PE
Peters
C J
CJ
D000062:Accidents, Occupational; D001117:Arenaviridae Infections / Q000517:prevention & control*; D018050:Arenavirus / Q000302:isolation & purification*; D003237:Connecticut; D016358:Contact Tracing; D006482:Hemorrhagic Fevers, Viral / Q000517:prevention & control*; D006785:Hospitals, University; D006801:Humans; D017053:Infection Control; D008297:Male; D008875:Middle Aged; D010356:Patient Isolation